MedTrace Logo

Integrated Treatment and Prevention for People Who Inject Drugs

NCT02935296 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1281

Last updated 2025-04-01

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility of a future trial that will assess whether an integrated intervention combining psychosocial counseling and supported referrals for antiretroviral therapy (ART) at any CD4 cell count and substance use treatment for HIV-infected people who inject drugs (PWID) will reduce HIV transmission to HIV-uninfected injection partners, as compared to routine care dictated by national guidelines for HIV-infected PWID.

Conditions

  • HIV Positive

Interventions

BEHAVIORAL

Integrated Intervention

systems navigation, psychosocial counseling

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • HIV Prevention Trials Network

    lead NETWORK

Principal Investigators

  • William Miller, MD · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-04
Primary Completion
2017-06-16
Completion
2018-06-30

Countries

  • Indonesia
  • Ukraine
  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02935296 on ClinicalTrials.gov